Beyond
the clinical effects of diseases like Alzheimer's and other dementias, these disorders also profoundly affect an individual's independence and quality of life as well as the lives of caregivers and others within the support system.
Not exact matches
There are several randomized controlled
clinical trials (RCTs) evaluating the
effect of probiotic bacteria on the prevention and treatment
of allergic
disease.
«Our study does not answer the question on possible reasons for infertility but it shows that periodontal bacteria may have a systemic
effect even in lower amounts, and even before clear
clinical signs
of gum
disease can be seen,» says Dr. Paju.
A
clinical trial assessing the potential
of the nutritional supplement inosine to treat Parkinson
disease has found that the studied dosages successfully raised participants» levels
of the antioxidant urate without producing serious side
effects.
Previous research raised the possibility that HDL might not be quite as protective against heart
disease as generally believed by cardiologists, especially after several
clinical trials
of HDL - raising drugs showed little or no
effect.
The neuroprotective
effects of nicotine were studied in a randomized
clinical trial involving 67 subjects in the early stages
of Alzheimer's
disease, where memory was slightly impaired but decision - making and other cognitive abilities remained intact.
«Imagine a drug that could act like Viagra in the inner ear,» says Lin, who notes that
clinical trials are already underway to study the
effects of such
disease - modifying drugs.
The authors do note that this large study can not definitively prove cause and
effect; nonetheless, the findings are strongly consistent with «a wealth
of existing observational and
clinical trial data to support health benefits
of nut consumption on many chronic
diseases.»
Whilst established to examine possible safety issues with biologic therapies, it provides the opportunity to look at additional benefits beyond the direct
effect on
disease severity,» explains William Dixon, MD, MRC clinician scientist / senior
clinical lecturer and honorary consultant rheumatologist; Arthritis Research UK Epidemiology Unit, The University
of Manchester; and an investigator in the study.
Of the 10 patients enrolled in the study — a clinical trial designed to evaluate safety and feasibility — none of the participants experienced any dangerous side effects and one patient's disease remained stable after 18 month
Of the 10 patients enrolled in the study — a
clinical trial designed to evaluate safety and feasibility — none
of the participants experienced any dangerous side effects and one patient's disease remained stable after 18 month
of the participants experienced any dangerous side
effects and one patient's
disease remained stable after 18 months.
«Since several BACE1 inhibitors are currently being evaluated in
clinical phase 3 trials for the treatment
of Alzheimer's
disease, the identification
of potential side
effects will be
of great importance to ensure a positive
clinical outcome,» said Dr. Jochen Herms, a Professor
of translational brain research at Ludwig - Maximilians - University Munich.
«Currently, we have ongoing
clinical trials where we are investigating the
effect of faecal microbiota transplantation in treating irritable bowel syndrome and inflammatory bowel
disease.»
«Millions
of volunteers have participated in
clinical trials to help find out more about the
effects of treatments on
disease, yet the important ethical issue
of reporting results has been ignored widely.
The program works by connecting computer - generated drug profiles — including mechanisms
of action,
clinical efficacy, and side
effects — with information about how a molecule may interact with human proteins in specific
diseases, such as ovarian cancer.
If doctors had known that TNF - blocking drugs mimic the
effects of a major risk factor for the
disease, they might have designed their
clinical trials differently, he says.
The study is investigator led and has therefore focused on
clinical need, targeting patients with progressive multiple sclerosis in whom most disability is incurred... The study also reports a predominant
effect on neurodegenerative rather than inflammatory outcomes, suggesting a novel mechanism
of action that might be suitable as combination treatment with immunomodulatory treatments... Further phase 3 studies to measure the
effect of simvastatin on sustained disability, particularly in patients with non-relapsing secondary progressive and primary progressive multiple sclerosis, are clearly needed, but this trial represents a promising point from which to develop trials
of progressive
disease.»
An initial
clinical trial
of simvastatin in people with early - stage MS showed reductions in brain lesions, suggesting an
effect on the underlying
disease process.
However, the authors stress that «further
clinical investigations will be essential to establish the optimal dose, duration and safety, and whether vitamin D2 or D3 have different
effects on mortality risk, since the available trials are based on elderly populations in general (an age group with high competing risk
of death often due to multiple co-existing
disease conditions) and they do not typically include cause - specific deaths as the primary outcomes.»
The FDA approved the combination
of Mekinist and Tafinlar through its accelerated approval program, which allows the agency to approve drugs to treat a serious
disease based on
clinical data showing the therapy has a proven
effect and
clinical benefit to patients.
Survivors should be assessed for physical (e.g.: urinary, sexual, bowel) and psychosocial
effects of prostate cancer and its treatment; the focus
of assessment should be tailored to the type
of cancer treatment received and current
disease state to trigger appropriate self - management and
clinical management strategies for support and therapy.
Appel and Sacks led three earlier
clinical trials that tested ways to reduce the risk
of cardiovascular
disease and diabetes, providing volunteers with carefully designed diets and measuring the
effects on key health indicators.
The meta - analysis included 16 randomized
clinical trials to assess the
effect of text messaging on medication adherence in chronic
disease.
Innovative
clinical trial approaches that have proven successful in other
disease areas such as oncology (e.g., platform trials, umbrella and basket designs) might be employed with stratification
of subjects by AT (N) profile, enabling a data - driven approach to identify the biological stage
of disease in which an intervention has maximal treatment
effects.
This
clinical trial is examining the
effects of an oral medication on those with mild to moderate Alzheimer's
disease currently on Aricept (Donepezil).
If sufficient 1,25 - dihydroxyvitamin D is produced, it may exert paracrine
effects on surrounding T lymphocytes, thereby regulating the tissue - specific immune responses.10 Some support for this hypothesis comes from recent experiments showing that mice fed diets high in vitamin D had significantly fewer
clinical and pathological signs
of EAE than mice fed a vitamin D — deficient diet.37 Central nervous system levels
of 1,25 - dihydroxyvitamin D, but not blood levels, were higher in supplemented mice than in vitamin D — deficient mice and correlated inversely with
disease severity.
Genetic data combined with information on gene expression and epigenomics in relevant tissues, and
clinical information, can provide clues about the
effects of genetic changes within an individual's genome that increase or decrease one's risk
of developing type 2 diabetes and its complications, including heart and kidney
disease.
Assessment
of young blood plasma in Alzheimer
Disease model Stanford's neuroscientist Tony Wyss - Coray, who studied
effects of «young blood» on brain rejuvenation, has started company (Alkahest) and
clinical trial 2 years ago.
A Competitor Mounts the Starting Blocks It would be exciting enough for one AS - targeting rejuvenation biotechnology (or one and a half, if PD03A is counted separately) were making such progress through the
clinical pipeline, especially in light
of the early hints
of a
disease - modifying
effect.
LUCIDITY, a new
clinical trial examining the
effects of LMTX ® in patients with mild Alzheimer's
disease, is now underway.
Phase II Trials
clinical studies conducted to evaluate the effectiveness
of the drug for a particular
disease or signs or symptoms in patients with the
disease or condition under study and to determine the common short - term side
effects and risks.
A potential explanation for the secular trend may be that while improved treatment for cardiovascular risk factors or complicating
diseases has reduced mortality in all weight classes, the
effects may have been greater at higher BMI levels than at lower BMI levels.12 Because obesity is a causal risk factor for hypertension, diabetes, cardiovascular
disease, and dyslipidemia,15,19 - 22 obese individuals may have had a higher selective decrease in mortality.18 Indirect evidence
of this
effect is seen in the findings as the deaths occur at similar time periods in the 3 cohorts, but cohorts recruited at later periods have an increase in the BMI associated with the lowest mortality, possibly suggesting a period
effect related to changes in
clinical practice, such as improved treatments, or general public health status, such as decreased smoking or increased physical activity.
In the journal Ter Arkh, the use
of an infrared sauna as part
of therapy
of 107 patients with asthma and chronic bronchitis «resulted in a rapid time course
of clinical symptoms
of diseases, reduced the adaptation period at a health resort, produced a bronchodilatatory
effect and helped to return cardiodynamics to normal...»
27 Studies cited by the 2010 DGAC Report demonstrate varied metabolic responses to lowered dietary saturated fat, with certain subpopulations exhibiting adverse rather than improved health outcomes.3 Two recent comprehensive meta - analyses indicate that saturated fat is not linked to heart
disease.28, 29 In fact, in a definitive review
of forty - eight
clinical trials, with over sixty - five thousand participants, the reduction or modification
of dietary fat had no
effect on mortality, cardiovascular mortality, heart attacks, stroke, cancer, or diabetes.30 Yet, avoiding saturated fat remains a cornerstone
of national dietary guidance.
Moreover, one study that had patients with celiac
disease consume properly fermented sourdough bread (which was found to contain < 10 ppm
of gluten) for 60 days found that there was no adverse
effect on
clinical symptoms or intestinal pathology.
A systematic review
of clinical trials on the health
effects of low carbohydrate diets from 2012 shows that low carb diets show significant decrease in body weight and an improvement
of all major risk factors for heart
disease.
The U.S. National Institutes
of Health counts 135 registered trials
of curcumin in the last 15 years, according to the study authors, but not one double - blind, placebo - controlled
clinical trial on curcumin can support all
of the benefits we've been attributing to it, and when it comes to research that seemed to prove curcumin's
effects on pancreatic and colon cancers, Alzheimer's
disease, and radiation - induced rashes, it seems that the supposed benefits are all cracked up.
In the mouse model
of multiple sclerosis (MS), a positive
effect of modified fasting and ketogenic nutrition (KD) on
disease development and
clinical course has been shown in several studies.
In the mouse model
of MS, experimental autoimmune encephalomyelitis (EAE), positive
effects of modified fasting and ketogenic nutrition on
disease onset and
clinical course in animals have been observed in several studies.
1935
Effects of the high carbohydrate - low calorie diet upon carbohydrate tolerance in diabetes mellitus 1955 Low - fat diet and therapeutic doses
of insulin in diabetes mellitus 1958
Effect of rice diet on diabetes mellitus associated with vascular
disease 1976 Beneficial
effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men 1977
Effect of carbohydrate restriction and high carbohydrates diets on men with chemical diabetes 1979 High - carbohydrate, high - fiber diets for insulin - treated men with diabetes mellitus 1981 High carbohydrate high in fibre diet in diabetes 1982 Response
of non-insulin-dependent diabetic patients to an intensive program
of diet and exercise 1983 Long - term use
of a high - complex - carbohydrate, high - fiber, low - fat diet and exercise in the treatment
of NIDDM patients 1994 Diet and exercise in the treatment
of NIDDM: the need for early emphasis 1999 Toward improved management
of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet 2005 The
effects of a low - fat, plant - based dietary intervention on body weight, metabolism, and insulin sensitivity 2006 A low - fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized
clinical trial in individuals with type 2 diabetes 2006
Effect of short ‐ term Pritikin diet therapy on the metabolic syndrome 2009 A low - fat vegan diet and a conventional diabetes diet in the treatment
of type 2 diabetes: a randomized, controlled, 74 - wk
clinical trial
A large number
of clinical studies have shown that the essential fats in salmon have direct
effect in reducing the risk
of arteriosclerosis and associated heart
diseases.
As
of June 2015, there were 116
clinical trials evaluating the possible anti-disease
effect of curcumin in humans, including studies on cancer, gastrointestinal
diseases, cognitive disorders, and psychiatric conditions.
Jay W. Pettegrew,
Clinical and neurochemical
effects of acetyl - L - carnitine in Alzheimer's
disease 1995.
Design: A systematic review
of the published literature through January 2015 was performed by using sensitive search strategies to identify randomized controlled
clinical trials that evaluated the
effects of fasting on either clinically relevant surrogate outcomes (e.g., weight, cholesterol) or actual
clinical event endpoints [e.g., diabetes, coronary artery
disease (CAD)-RSB- and any other studies that evaluated the
effects of fasting on
clinical event outcomes.
Laboratory and
clinical studies on ayurvedic herbal preparations and other therapies have shown them to have a range
of potentially beneficial
effects for preventing and treating certain cancers, treating infectious
disease, promoting health, and treating aging.
For example, KBs were recently reported to act as neuroprotective agents by raising ATP levels and reducing the production
of reactive oxygen species in neurological tissues, 80 together with increased mitochondrial biogenesis, which may help to enhance the regulation
of synaptic function.80 Moreover, the increased synthesis
of polyunsaturated fatty acids stimulated by a KD may have a role in the regulation
of neuronal membrane excitability: it has been demonstrated, for example, that polyunsaturated fatty acids modulate the excitability
of neurons by blocking voltage-gated sodium channels.81 Another possibility is that by reducing glucose metabolism, ketogenic diets may activate anticonvulsant mechanisms, as has been reported in a rat model.82 In addition, caloric restriction per se has been suggested to exert neuroprotective
effects, including improved mitochondrial function, decreased oxidative stress and apoptosis, and inhibition
of proinflammatory mediators, such as the cytokines tumour necrosis factor - α and interleukins.83 Although promising data have been collected (see below), at the present time the real
clinical benefits
of ketogenic diets in most neurological
diseases remain largely speculative and uncertain, with the significant exception
of its use in the treatment
of convulsion
diseases.
A double - blind, randomized,
clinical trial
of the
effect of vitamin A and zinc supplementation on diarrheal
disease and respiratory tract infections in children in Mexico City, Mexico.
To date, no trial has tested the
effects of increased fruit and vegetable on
clinical CVD outcomes (i.e., coronary heart
disease events, stroke).
First, most
of the evidence regarding the
disease effects of carbohydrate to fat ratio is derived from epidemiological and observational studies because it is difficult to address
disease endpoints through
clinical trials.
Speaking
of clinical solutions, you should be aware that products such as Viagra, Cialis, and Levitra may cause certain side
effects and unpleasant symptoms in men that have a history
of cardiovascular
disease.
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve
Disease and Cardiomegaly: The EPIC Study — A Randomized
Clinical Trial.